Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL


Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

01-March-2024 / 14:22 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France

 

 

 

 

 

 

DECLARATION RELATIVE TO

THE NUMBER OF SHARES AND VOTING RIGHTS

MAKING UP THE ISSUED CAPITAL

 

Article L 233-8-II of the Code of commerce

and article 223-6 of the general regulations of the AMF

 

 

 

 

Designation of issuer

 

 

 

SARTORIUS STEDIM BIOTECH SA

CS 91051

Z. I. Les Paluds

Avenue de Jouques

13781 Aubagne Cedex

 

 

 

Date of information
 

Total number of shares making up the issued capital

Total number of theoretical voting rights including treasury shares

Total number of net voting rights

February 29, 2024

97,330,405

165,579,858

165,562,569

 

 


Regulatory filing PDF file

File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL


Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: [email protected]
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext Ticker: DIM
AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital
EQS News ID: 1849799
 
End of Announcement EQS News Service

1849799  01-March-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1849799&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

Sartorius Stedim Biotech S.A. Aktie

211,60 €
1,24 %
Die Sartorius Stedim Biotech S.A. Aktie erlebt heute einen merklichen Anstieg, um 1,24 %.

Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare